iTonic Holdings (ITOC) Operating Leases (2023 - 2024)
iTonic Holdings' (ITOC) quarterly Operating Leases came in at $74132.0 in Q2 2024, down 29.39% quarter-over-quarter from $104993.0 in Q4 2023.
Powered by 
Analysis
iTonic Holdings (ITOC) Operating Leases (2023 - 2024) Analysis & Trends
iTonic Holdings has disclosed Operating Leases across 2 years of filings, most recently posting $74132.0 for Q2 2024.
- In Q2 2024, Operating Leases changed N/A year-over-year to $74132.0; the TTM figure through Jun 2024 stood at $74132.0 (changed N/A YoY), while the FY2023 annual figure was $104993.0, changed N/A from the prior year.
- Operating Leases came in at $74132.0 for Q2 2024 at iTonic Holdings, down from $104993.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $104993.0 in Q4 2023 to a low of $74132.0 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.71 Bn | 174.10 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.38 Bn | 6.34 Bn |
| 4 | Stryker | 104.00 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.32 Bn | 62.78 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.70 Bn | 1.35 Bn |
| 7 | Alcon | 32.88 Bn | 31.43 Bn | 1.68 Bn |
| 8 | Dexcom | 32.27 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | iTonic Holdings | 4.83 Mn | 1.90 Mn | - |